Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12759]

ASCO 2020: Chemo within 3 months of COVID-19 diagnosis associated with an increased risk of death in patients with thoracic cancer

ASCO 2020: Chemo within 3 months of COVID-19 diagnosis associated with an increased risk of death in patients with...

Blocking tumour signals can hinder cancer's spread

Blocking tumour signals can hinder cancer's spread

A comprehensive survey reveals bacteria are widespread in human tumours and differ by tumour type

A comprehensive survey reveals bacteria are widespread in human tumours and differ by tumour type

ASCO 2020: Large scale precision medicine approach successfully applied to paediatric cancers with poor prognosis

ASCO 2020: Large scale precision medicine approach successfully applied to paediatric cancers with poor prognosis

ASCO 2020: Special report provides guidance to oncology practices on resuming cancer care during COVID-19 pandemic

ASCO 2020: Special report provides guidance to oncology practices on resuming cancer care during COVID-19 pandemic

ASCO 2020: Early data show cancer progression associated with increased risk of death in patients with COVID-19

ASCO 2020: Early data show cancer progression associated with increased risk of death in patients with COVID-19

Anti-malarial drug shows promise for brain cancer treatment

Anti-malarial drug shows promise for brain cancer treatment

New cancer immunotherapy targeting myeloid cells slows tumour growth

New cancer immunotherapy targeting myeloid cells slows tumour growth

Study could lead to new scale for stratifying neuroblastoma risk

Study could lead to new scale for stratifying neuroblastoma risk

FDA approves nivolumab plus ipilimumab and chemotherapy for first-line treatment of metastatic NSCLC

FDA approves nivolumab plus ipilimumab and chemotherapy for first-line treatment of metastatic NSCLC

More from ecancer